- Home
- BRTX vs AIHS Comparison
BRTX vs AIHS Comparison
Compare BRTX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- AIHS
- Stock Information
- Founded
- BRTX 1997
- AIHS 2014
- Country
- BRTX United States
- AIHS China
- Employees
- BRTX N/A
- AIHS N/A
- Industry
- BRTX Managed Health Care
- AIHS Finance: Consumer Services
- Sector
- BRTX Health Care
- AIHS Finance
- Exchange
- BRTX Nasdaq
- AIHS Nasdaq
- Market Cap
- BRTX 11.2M
- AIHS 9.5M
- IPO Year
- BRTX N/A
- AIHS 2018
- Fundamental
- Price
- BRTX $1.85
- AIHS $0.90
- Analyst Decision
- BRTX Strong Buy
- AIHS
- Analyst Count
- BRTX 1
- AIHS 0
- Target Price
- BRTX $18.00
- AIHS N/A
- AVG Volume (30 Days)
- BRTX 48.0K
- AIHS 10.4K
- Earning Date
- BRTX 03-27-2025
- AIHS 02-14-2025
- Dividend Yield
- BRTX N/A
- AIHS N/A
- EPS Growth
- BRTX N/A
- AIHS N/A
- EPS
- BRTX N/A
- AIHS N/A
- Revenue
- BRTX $401,000.00
- AIHS $5,878,700.00
- Revenue This Year
- BRTX $482.76
- AIHS N/A
- Revenue Next Year
- BRTX $212.24
- AIHS N/A
- P/E Ratio
- BRTX N/A
- AIHS N/A
- Revenue Growth
- BRTX 175.03
- AIHS 12.21
- 52 Week Low
- BRTX $1.03
- AIHS $0.74
- 52 Week High
- BRTX $2.55
- AIHS $1.45
- Technical
- Relative Strength Index (RSI)
- BRTX 53.36
- AIHS 50.79
- Support Level
- BRTX $1.72
- AIHS $0.86
- Resistance Level
- BRTX $1.85
- AIHS $1.04
- Average True Range (ATR)
- BRTX 0.13
- AIHS 0.06
- MACD
- BRTX 0.02
- AIHS 0.00
- Stochastic Oscillator
- BRTX 50.98
- AIHS 23.33
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.